Lifevantage Corp
جودة البيانات: 100%
LFVN
NASDAQ
Manufacturing
Chemicals
KWD 4.15
▲
KWD 0.13
(3.23%)
القيمة السوقية: 53.14 M
السعر
KWD 4.15
القيمة السوقية
53.14 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue grew 0.93% annually over 5 years — modest growth
Earnings grew 233.84% over the past year
ROE of 23.77% indicates high profitability
Generating 1.70 M in free cash flow
P/E of 6.76 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13.24%
النمو
Revenue Growth (5Y)
0.93%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)14.17%
Earnings (1Y)233.84%
FCF Growth (3Y)67.14%
الجودة
Return on Equity
23.77%
أعلى من متوسط القطاع (-54.01%)
ROIC17.85%
Net Margin3.74%
Op. Margin4.26%
الأمان
Debt / Equity
N/A
Current Ratio2.03
Interest CoverageN/A
التقييم
PE (TTM|NTM|2027)
6.76 | 6.77 | 6.77
أعلى من متوسط القطاع (-1.49)
P/B Ratio1.61
EV/EBITDA4.48
Dividend Yield4.34%
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 6.8 | -1.5 |
| P/B | 1.6 | 1.6 |
| ROE % | 23.8 | -54.0 |
| Net Margin % | 3.7 | -41.5 |
| Rev Growth 5Y % | 0.9 | 1.8 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
2 محللين
Buy
الحالي
KWD 4.15
المستهدف
KWD 8.00
KWD 5.00
KWD 8.00
KWD 11.00
التوقعات
مكرر الربحية المستقبلي
6.77
ربحية السهم المستقبلية
KWD 0.61
نمو ربحية السهم (تقدير)
-8.9%
الإيرادات المقدّرة
191.09 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 0.61
KWD 0.47 – KWD 0.70
|
191.09 M | 3 |
| FY2026 |
KWD 0.67
KWD 0.65 – KWD 0.69
|
192.75 M | 3 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
KWD 0.19
KWD 0.17 – KWD 0.22
|
48.55 M | 3 |
| 2026 Q1 |
KWD 0.16
KWD 0.14 – KWD 0.17
|
47.77 M | 3 |
مفاجآت الأرباح
آخر 6 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | KWD 0.15 | KWD 0.15 | 0.0% |
| Q32025 | KWD 0.19 | KWD 0.18 | -5.3% |
| Q22025 | KWD 0.20 | KWD 0.17 | -12.8% |
| 2026-Q2 | KWD 0.19 | KWD 0.02 | -89.5% |
| 2026-Q1 | KWD 0.16 | KWD 0.17 | +8.5% |
| Q12025 | KWD 0.15 | KWD 0.26 | +79.3% |
Dividend History
Yield
4.34%
Payout Ratio
30.00%
Growth (3Y)
24.81%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 02, 2026 | — | KWD 0.05 | N/A |
| Dec 01, 2025 | — | KWD 0.05 | N/A |
| Sep 08, 2025 | — | KWD 0.05 | N/A |
| May 30, 2025 | — | KWD 0.05 | N/A |
| Mar 03, 2025 | — | KWD 0.04 | N/A |
| Dec 02, 2024 | — | KWD 0.04 | N/A |
| Sep 09, 2024 | — | KWD 0.04 | N/A |
| May 31, 2024 | — | KWD 0.04 | N/A |
| Feb 29, 2024 | — | KWD 0.04 | N/A |
| Nov 30, 2023 | — | KWD 0.04 | N/A |
| Sep 07, 2023 | — | KWD 0.44 | N/A |
| May 31, 2023 | — | KWD 0.04 | N/A |
| Feb 28, 2023 | — | KWD 0.03 | N/A |
| Nov 30, 2022 | — | KWD 0.03 | N/A |
| Sep 01, 2022 | — | KWD 0.03 | N/A |
| May 16, 2022 | — | KWD 0.03 | N/A |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.17% | Revenue Growth (3Y) | 3.48% |
| Earnings Growth (1Y) | 233.84% | Earnings Growth (3Y) | 96.47% |
| Revenue Growth (5Y) | 0.93% | Earnings Growth (5Y) | -6.62% |
| Profitability | |||
| Revenue (TTM) | 210.05 M | Net Income (TTM) | 7.86 M |
| ROE | 23.77% | ROA | 12.81% |
| Gross Margin | 78.75% | Operating Margin | 4.26% |
| Net Margin | 3.74% | Free Cash Flow (TTM) | 1.70 M |
| ROIC | 17.85% | FCF Growth (3Y) | 67.14% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.03 |
| Interest Coverage | N/A | Asset Turnover | 3.42 |
| Working Capital | 19.54 M | Tangible Book Value | 29.20 M |
| Dividends | |||
| Dividend Yield | 4.34% | Payout Ratio | 30.00% |
| Dividend Growth (3Y) | 24.81% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 4 yrs | ||
| Valuation | |||
| P/E Ratio | 6.76 | Forward P/E | 6.77 |
| P/B Ratio | 1.61 | P/S Ratio | 0.25 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 4.48 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.28 | Fwd Earnings Yield | 14.77% |
| FCF Yield | 3.19% | ||
| Market Cap | 53.14 M | Enterprise Value | 53.14 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.60 | Revenue / Share | 16.40 |
| FCF / Share | 0.13 | OCF / Share | 0.29 |
| EPS CAGR (1Y) | 226.09% | EPS CAGR (5Y) | -4.46% |
| EPS CAGR (10Y) | 6.94% | ||
| Efficiency | |||
| CapEx / Revenue | 0.98% | FCF Conversion | 21.56% |
| SBC-Adj. FCF | -2.12 M | Growth Momentum | 13.24 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 228.53 M | 200.16 M | 213.40 M | 206.36 M | 220.18 M |
| Net Income | 9.81 M | 2.94 M | 2.54 M | 3.12 M | 12.89 M |
| EPS (Diluted) | 0.75 | 0.23 | 0.20 | 0.24 | 0.90 |
| Gross Profit | 183.67 M | 158.72 M | 170.01 M | 168.26 M | 181.99 M |
| Operating Income | 12.20 M | 4.33 M | 4.26 M | 7.58 M | 17.62 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 1.40 M | 700,000.0 | 600,000.0 | 700,000.0 | 700,000.0 |
| SG&A Expenses | 69.21 M | 68.47 M | 71.07 M | 63.43 M | 60.84 M |
| D&A | 3.16 M | 3.58 M | 3.58 M | 3.26 M | 3.46 M |
| Interest Expense | — | -430,000.0 | -198,000.0 | 10,000.0 | 17,000.0 |
| Income Tax | 2.44 M | 1.41 M | 1.46 M | 1.57 M | 4.34 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 71.96 M | 60.30 M | 66.12 M | 70.71 M | 78.73 M |
| Total Liabilities | 37.32 M | 34.31 M | 31.47 M | 39.19 M | 41.93 M |
| Shareholders' Equity | 34.64 M | 25.99 M | 34.65 M | 31.52 M | 36.81 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 20.20 M | 16.89 M | 21.61 M | 20.19 M | 23.17 M |
| Current Assets | 50.89 M | 37.65 M | 44.28 M | 46.96 M | 48.05 M |
| Current Liabilities | 27.22 M | 22.31 M | 19.61 M | 25.73 M | 25.20 M |
درجات الاستراتيجيات
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
النشاط الأخير
دخل
Dividend Growth
Apr 12, 2026
دخل
High Yield Value
Apr 12, 2026
دخل
Contrarian Investing (David Dreman)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"LFVN","listing_kind":"stock","pathname":"/stocks/lfvn","exchange":"NASDAQ","country":"US"}}




